Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QuantaLife Inc.

Division of Bio-Rad Laboratories Inc.
www.quantalife.com

Latest From QuantaLife Inc.

Deals In Depth: October 2011

October’s dealmaking highlights: Biogen received exclusive global rights to Portola’s autoimmune and anti-inflammatory Syk inhibitors in an alliance worth $554 million. Investment firms took public CRO Pharmaceutical Product Development private for $33.25 per share, or a total of $3.9 billion, including debt. Regeneron’s $391 million notes sale propelled the debt category to claim almost half of the $826 million biopharma financing figure. Meantime device companies raised $206 million, mainly from Zeltiq’s $93 million IPO.

BioPharmaceutical Medical Device

Deals Shaping The Medical Industry (11/2011)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Bio-Rad Laboratories Inc.
  • Senior Management
  • Bill, Jr. W Colston, PhD, CEO
    Paul Kidman, VP, Fin.
    Ben Hindson, PhD, CSO
    Isaac Bright, MD, VP, Corp. Dev.
  • Contact Info
  • QuantaLife Inc.
    Phone: (925) 474-8600
    7068 Koll Center Pkwy.
    Ste. 401
    Pleasanton, CA 94566
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register